Sign in with Google. Opens in new tab
ENTITY
Medy Tox Inc

Medy Tox Inc (086900 KS)

56
Analysis
Health CareSouth Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
28 Mar 2019 13:42

Smartkarma’s Week That Was in JP/​​​​​​​​KR: Semiconductor Warnings, Exit of Chairman Cho, & 청년수당

In the past week, there were earnings warnings from three major players in the global semiconductor sector, including Samsung Electronics (005930...

Logo
679 Views
Share
27 Mar 2019 23:36

Daewoong: Entering "Botox World"

Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...

Share
26 Nov 2018 21:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
416 Views
Share
17 Jan 2018 07:06

KRX 300 - Selection Process Summary & Current Mood

Feb 5 is our big day. On Feb 5 the KRX will announce more details about this highly anticipated and much awaited new KOSPI+KOSDAQ integrated...

Logo
616 Views
Share
25 Nov 2017 13:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
610 Views
Share
x